Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Hercules Capital is a specialty finance company providing venture debt and equipment financing to venture capital-backed technology and life sciences companies, primarily in the United States. The firm operates as a business development company (BDC) with a portfolio concentrated in growth-stage companies across software, healthcare technology, and sustainable/renewable technology sectors. Its competitive position stems from deep relationships with top-tier VC firms, specialized underwriting expertise in high-growth sectors, and a differentiated lending model that captures equity upside through warrants.
Hercules originates senior secured debt facilities typically ranging from $5-50 million to venture-backed companies that lack access to traditional bank financing. The firm charges interest rates typically in the 10-14% range (as of early 2026 market conditions), plus origination fees of 1-3% and receives equity warrants representing 5-15% warrant coverage on loan commitments. Pricing power derives from limited competition in the venture debt space, specialized credit expertise in assessing pre-profitable growth companies, and the ability to move quickly on transactions. The BDC structure requires distributing at least 90% of taxable income as dividends, making it attractive to income-focused investors. Operating leverage is moderate - the firm has fixed overhead for underwriting and portfolio management teams, but marginal costs for incremental loans are relatively low once infrastructure is built.
Net investment income (NII) per share and dividend coverage ratio - ability to sustain or grow quarterly distributions
Portfolio credit quality metrics - non-accrual rates, realized losses, and migration of portfolio companies to later funding rounds or exits
New loan origination volumes and deployment rates - ability to put capital to work at attractive yields
Warrant monetization events - IPOs or M&A exits of portfolio companies generating realized gains
Changes in base interest rates (SOFR/Prime) affecting floating-rate loan yields and cost of debt capital
Venture capital market cyclicality - prolonged downturn in VC fundraising and deployment (2023-2026 has seen significant contraction from 2021 peaks) reduces origination opportunities and increases refinancing risk for existing portfolio
Regulatory constraints on BDC leverage and asset coverage requirements limit growth flexibility and force equity dilution during expansion phases
Technology sector concentration risk - estimated 60-70% portfolio exposure to software, fintech, and digital infrastructure creates correlated default risk during tech downturns
Increased competition from traditional banks expanding into venture debt (Silicon Valley Bank's collapse in 2023 initially reduced competition but larger banks have entered), private credit funds, and other BDCs compressing spreads
Direct lending by venture capital firms to their portfolio companies (insider rounds) reducing third-party debt demand
Alternative financing structures like revenue-based financing and venture debt platforms disintermediating traditional lenders
Leverage constraints under BDC regulations - currently operating near 1.0-1.2x debt-to-equity limits based on asset coverage tests, restricting growth without equity raises
Mark-to-market volatility in warrant portfolio and equity investments creating NAV fluctuations that don't reflect core lending performance
Concentration risk in portfolio - top 10 investments likely represent 15-25% of total portfolio value, creating single-name exposure risk
high - Venture debt demand is highly correlated with venture capital fundraising activity and technology sector growth. During economic downturns, VC funding slows dramatically, reducing loan origination opportunities. Portfolio companies face higher default risk when unable to raise follow-on equity rounds. However, the firm benefits from floating-rate loan structures that capture rising base rates. The 27% revenue growth suggests strong recent deployment, but the -27% one-year stock return reflects investor concerns about credit quality deterioration in a higher-rate environment.
Dual impact - Rising rates are initially positive for net interest income as the majority of the loan portfolio is floating-rate (typically SOFR + 700-900 bps spread), while the firm's credit facilities also float but at lower spreads. However, sustained high rates negatively impact portfolio company valuations, reduce VC fundraising and deployment, and increase refinancing stress for borrowers. The current environment (February 2026) with elevated rates has compressed venture activity significantly from 2021-2022 peaks. Valuation multiples for BDCs also compress as Treasury yields rise, making the dividend yield less attractive on a relative basis.
Extreme - Credit conditions are the primary determinant of business performance. Hercules lends to pre-profitable, cash-burning companies dependent on continued equity financing. Tightening credit conditions or reduced VC activity directly increases default risk. The firm's underwriting focuses on companies with 12-18 months of cash runway and strong VC sponsor support, but deteriorating credit markets can trigger rapid portfolio quality decline. High yield credit spreads and venture capital exit activity are leading indicators of portfolio stress.
dividend - BDC structure mandates high dividend payout ratios (90%+ of taxable income), attracting income-focused investors seeking yields in the 9-12% range. However, recent stock underperformance (-27% over one year) suggests growth investors have exited due to concerns about credit quality and reduced origination volumes in the current venture capital environment. Value investors may find opportunity if trading below NAV with sustainable dividend coverage.
high - BDC stocks exhibit elevated volatility due to quarterly NAV mark-to-market adjustments, episodic credit events, and sensitivity to both interest rate changes and venture capital market sentiment. The stock's -27% one-year return versus -7.5% three-month return suggests recent stabilization but ongoing uncertainty. Beta likely in the 1.3-1.6 range relative to broader market.
